Follow Us on Google+

Request A Price Quote:

NIIN Output Data

NIIN:
NSN:
Item Name:
ENALAPRILAT INJECTION

Definition:

Reference/Part Number

Part Number CAGE Status RNCC RNVC DAC RNAAC MSDS SADC
NDC00006-3508-04 06990 A 3 2 4 KX
NDC00074-2122-02 23281 A 5 2 4 ZZ
VASOTEC IV 06990 A 5 1 4 KX
NDC10019-0092-04 04687 A 5 2 4 ZZ
NDC61703-0237-16 05BB8 A 5 2 4 ZZ
NDC10019-0095-04 04687 A 5 2 4 ZZ

CAGE Information

Code Company
04687 BAXTER HEALTHCARE CORP IV SYSTEMS/GO
06990 MERCK SHARP & DOHME CORP. DBA MERCK
23281 ABBOTT LABORATORIES INC ROSS PRODUCT
05BB8 FAULDING PHARMACEUTICALS

Federal Supply Class

Title

DRUGS AND BIOLOGICALS

Inclusions:

INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.

Exclusions:

EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.

Characteristics (Decoded)

MRC Requirements Statement Clear Text Reply
CQCT PRIMARY CONTAINER TYPE VIAL
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 1.250 MILLIGRAMS ENALAPRILAT,ANHYDROUS PER MILLILITER
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY ENALAPRILAT INJECTION 1.25MG ANHYDROUS ENALAPRILAT
AJCN PROTECTIVE STORAGE FEATURE SUBJECT TO DAMAGE BY FREEZING
CRLK PRIMARY CONTAINER CONTENT QUANTITY 1.250 MILLILITERS

Similar Parts

NDC10019-0092-04 , NDC10019009204 , 6505-01-305-6988 , 6505013056988 , 013056988 , NDC00006-3508-04 , NDC00074-2122-02 , VASOTEC IV , NDC10019-0092-04 , NDC61703-0237-16 , NDC10019-0095-04 ,